Sponsored by
Latest
Topics
Topics
Accounting & Tax
Corporate Finance
Human Capital
Risk & Compliance
Strategy
Technology
Featured
Regulation
4 Regulatory Developments to Follow in 2023
Federal government regulators are taking aggressive stances to protect workers, ensure fair markets, and keep investors informed.
By
Vincent Ryan
| January 31, 2023
Read More
Resources
CFO Live
2022 Survey
Sign Up
Menu
Topics
Accounting & Tax
Corporate Finance
Human Capital
Risk & Compliance
Strategy
Technology
Explore
Search
Latest
Resources
CFO Live
2022 Survey
Sign Up
Sponsored by
Regado Biosciences
Risk & Compliance
Drug Investigator Accused of Insider Trading
The SEC says cardiologist Edward Kosinski traded in the shares of Regado Biosciences based on his knowledge of a heart drug trial.
By
Matthew Heller
| August 5, 2016
Read More
